Tesamorelin/Ipamorelin

FDA APPROVAL PENDING

Limited Research

Growth

Metabolic

Healing

Tesamorelin/Ipamorelin

Tesamorelin + Ipamorelin GH Secretagogue Blend

Learn more

Growth

Tesamorelin/Ipamorelin

Metabolic

Amino acid sequence

35

Amino acids

0da

Molecular weight

Blend

Type

The Tesa/IPA blend combines two complementary growth hormone secretagogues: Tesamorelin (a GHRH analog that stimulates GH release from the pituitary) and Ipamorelin (a selective ghrelin mimetic/GHRP that amplifies GH pulses). This combination addresses both the GHRH and GHRP pathways for synergistic GH release. Common formulations include 5mg/5mg (1:1 ratio) and 10mg/3mg (higher Tesamorelin) variants. Tesamorelin is FDA-approved for HIV-associated lipodystrophy, while Ipamorelin remains investigational.

Top researched benefits

Overview of Tesamorelin/Ipamorelin

The blend leverages two distinct GH-releasing pathways: Tesamorelin is a synthetic GHRH analog that directly stimulates growth hormone-releasing hormone receptors on pituitary somatotrophs, triggering GH synthesis and secretion in a pulsatile, physiological manner. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that amplifies GH pulses without significantly affecting cortisol or prolactin. Together, they produce synergistic GH release greater than either compound alone, while maintaining the body's natural feedback mechanisms.

body composition

  • Tesamorelin has demonstrated fat reduction in clinical trials; synergy with Ipamorelin may enhance effects.
  • Tesamorelin specifically reduces visceral adipose tissue (FDA-approved indication).
  • Enhanced GH promotes protein synthesis and lean tissue preservation.

recovery and wellness

  • GH secretagogues often improve deep sleep quality.
  • Enhanced GH supports tissue repair and recovery from exercise.
  • Restoring more youthful GH levels may provide anti-aging benefits.

metabolic health

  • Tesamorelin has shown improvements in lipid parameters in studies.
  • Increased GH leads to increased IGF-1 production.

Typical Dose

200-500mcg total blend per injection

Frequency

Once daily (evening preferred) or twice daily for advanced protocols

Cycle Duration

8-16 weeks continuous

Storage

Reconstituted: 2-8°C, use within 4-6 weeks

Chemical Makeup

Key benefits

Synergistic GH release from dual pathways

More physiological pulsatile GH secretion

Tesamorelin's proven lipodystrophy benefits

Ipamorelin's clean side effect profile

Does not significantly affect cortisol or prolactin

Single injection convenience

May improve body composition, sleep, and recovery

Community interest

This peptide is still gaining traction in the community.

Tesamorelin + Ipamorelin GH Secretagogue Blend

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Tesamorelin/Ipamorelin Molecular Information

View the scientifc details of Tesamorelin/Ipamorelin .

35

Amino Acids

Tesamorelin/Ipamorelin

Thr

Thr

Position 1

Glu

Glu

Position 2

Ser

Ser

Position 3

Ala

Ala

Position 4

Met

Met

Position 5

Pyl

Pyl

Position 6

Arg

Arg

Position 7

Glu

Glu

Position 8

Leu

Leu

Position 9

Ile

Ile

Position 10

Asn

Asn

Position 11

Gly

Gly

Position 12

His

His

Position 13

Arg

Arg

Position 14

His

His

Position 15

Ala

Ala

Position 16

Asn

Asn

Position 17

Ala

Ala

Position 18

Leu

Leu

Position 19

Pyl

Pyl

Position 20

Gly

Gly

Position 21

Ile

Ile

Position 22

Pro

Pro

Position 23

Ala

Ala

Position 24

Met

Met

Position 25

Pyl

Pyl

Position 26

Arg

Arg

Position 27

Glu

Glu

Position 28

Leu

Leu

Position 29

Ile

Ile

Position 30

Asn

Asn

Position 31

Gly

Gly

Position 32

His

His

Position 33

Arg

Arg

Position 34

Pro

Pro

Position 35

Amino acid sequence
ThreoninePosition 1
Glutamic acidPosition 2
SerinePosition 3
AlaninePosition 4
MethioninePosition 5
PyrrolysinePosition 6
ArgininePosition 7
Glutamic acidPosition 8
LeucinePosition 9
IsoleucinePosition 10
AsparaginePosition 11
GlycinePosition 12
HistidinePosition 13
ArgininePosition 14
HistidinePosition 15
AlaninePosition 16
AsparaginePosition 17
AlaninePosition 18
LeucinePosition 19
PyrrolysinePosition 20
GlycinePosition 21
IsoleucinePosition 22
ProlinePosition 23
AlaninePosition 24
MethioninePosition 25
PyrrolysinePosition 26
ArgininePosition 27
Glutamic acidPosition 28
LeucinePosition 29
IsoleucinePosition 30
AsparaginePosition 31
GlycinePosition 32
HistidinePosition 33
ArgininePosition 34
ProlinePosition 35

Molecular Weight

0Da

Chain Length

35Amino Acids

Type

Blend

Tesamorelin/Ipamorelin Protocols

Subcutaneous injection, typically administered before bed or in the morning on an empty stomach. Evening dosing may enhance natural nighttime GH pulse. Avoid eating 2-3 hours before and 30-60 minutes after injection for optimal results.

GoalDosageFrequencyRoute
Standard protocol (5/5 blend)2001 week rangeSubQ
Enhanced protocol (10/3 blend)3001 week rangeSubQ
Twice daily (advanced)200SubQ

Reconstitution Instructions

Materials needed:

Tesa/IPA vial (5/5mg or 10/3mg)Bacteriostatic water (2-3mL)Insulin syringesAlcohol prep pads

Steps to reconstitute

  1. Clean vial top with alcohol pad
  2. Add 2mL bacteriostatic water for convenient dosing
  3. Gently swirl - do not shake
  4. Solution should appear clear
  5. Label with date and concentration
  6. Store refrigerated immediately
  7. Use within 4-6 weeks

Tesamorelin/Ipamorelin Cycle

The Tesamorelin/Ipamorelin Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Improved sleep quality often noticed first; initial GH response
Week 2-4
Enhanced recovery; subtle body composition changes beginning
Week 4-8
Noticeable fat loss (especially visceral); improved energy
Week 8-16
Full body composition benefits; continued improvements

Dosing tools

Tesamorelin/Ipamorelin Blend Dosage Calculator

Calculate blended peptide doses with our visual syringe guide.

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

1 mL

2 mL

3 mL

5 mL

Custom

Custom Blend Compounds

Total: 10.0 mg

mg

mg

The dose of the anchor peptide you want per administration, in mcg or mg.

Conversion: 1,000 mcg = 1 mg

Results

Concentration

10.00

mg/mL

Doses per vial

20

Total blend to inject

0.50

mg

You'll get:

Ipamorelin
250 mcgANCHOR
Tesamorelin
250 mcg

1mL / 100 units

5 units

0.050 mL

Dosing Guidance

Recommended Schedule

Once daily (evening preferred) or twice daily for advanced protocols

Supply Duration

This vial provides 20 doses (20-day supply at 250 mcg daily)

Peptide Interactions

Research suggestions of Tesamorelin/Ipamorelin interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

Different mechanisms; can complement for healing with GH support.

COMPATIBLE

Weight

mk6

Growth

MK-677

MONITOR

Both affect GH release; combination may be excessive and affect glucose.

MONITOR

Weight

sem

Metabolic

Semaglutide

COMPATIBLE

Different pathways; some combine for body composition goals.

COMPATIBLE

Side effects

Monitor: Be careful when combining Tesamorelin/Ipamorelin with MK-677.

Contraindications

Active malignancy (GH may promote tumor growth)

Diabetic retinopathy

Pregnancy or breastfeeding

Pituitary disorders

Hypersensitivity to components

Stop signs

Severe injection site reactions

Significant swelling or edema

Signs of glucose dysregulation

Severe joint pain

Allergic reactions

Bad signs

No Certificate of AnalysisCannot verify Tesamorelin:Ipamorelin ratioDiscolored or particulate solution
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

Tesamorelin/Ipamorelin Research References

Tesamorelin/Ipamorelin is a limited research compound

4Research references

Tesamorelin/Ipamorelin

Tesamorelin/Ipamorelin is a limited research compound

Tesamorelin FDA Approval for HIV Lipodystrophy

Tesamorelin (Egrifta) approved for reduction of excess abdominal fat in HIV patients.

n.d.

Tesamorelin Effects on Visceral Fat

Tesamorelin significantly reduces visceral adipose tissue and improves lipid profiles.

n.d.

Ipamorelin Selectivity Profile

Ipamorelin selectively releases GH without affecting cortisol, prolactin, or ACTH.

n.d.

GHRH + GHRP Synergy

Combining GHRH and GHRP pathways produces synergistic GH release greater than either alone.

n.d.